Fosnetupitant + Palonosetron
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Fosnetupitant
fosnetupitant - Palonosetron
palonosetron
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| Fosnetupitant and PalonosetronUS | 260 mg / 0.28 mg | Helsinn Therapeutics (U.S.), Inc. |
| fosnetupitant + palonosetrónAUES | 235 mg / 0.25 mg | Arrotex Pharmaceuticals Pty Ltd |
| Akynzeo IVAU | 235 mg / 0.25 mg | Arrotex Pharmaceuticals Pty Ltd |
| palonosetron hydrochloride + fosnetupitant chloride hydrochloride + palonosetron + fosnetupitantAU | — | — |
| 嘔可舒注射液TW | — | 和聯生技藥業股份有限公司 |
| Akynzeo Concentrate for solution for infusionTW | — | 和聯生技藥業股份有限公司 |
| Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vialSG | 235 mg/vial / 0.25 mg/vial | JUNIPER BIOLOGICS PTE LTD |
| AKYNZEO CONCENTRATE FOR SOLUTION FOR INFUSION 235MG/0.25MG IN 20MLHK | — | FOSUN INDUSTRIAL CO., LIMITED |
| AKYNZEO IV fosnetupitant (as chloride hydrochloride)/palonosetron (as hydrochloride) 235 mg/250 microgram concentrated injection vialAU | 260 mg / 280 microgram | Juniper Biologics Pty Ltd |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.